There is no evidence that PUFA supplementation in infancy has an effect on infant or childhood allergy , asthma , dermatitis/eczema or food allergy .
However , the quality of evidence was very low .
There was insufficient evidence to determine an effect on allergic rhinitis
BACKGROUND Early dietary intakes may influence the development of allergic disease .
It is important to determine if dietary polyunsaturated fatty acids ( PUFAs ) given as supplements or added to infant formula prevent the development of allergy .
OBJECTIVES To determine the effect of higher PUFA intake during infancy to prevent allergic disease .
Early neurological and neurophysiological development of the preterm infant and polyunsaturated fatty acids supply
OBJECTIVES To compare the early neurological maturation of premature newborns ( PT ) fed breast milk ( BM ) or a formula containing only 18-carbon polyunsaturated fatty acids ( PUFA ) (  A ) or enriched with long chain ( LC ) PUFA ( B ) . METHODS PT enrolled the 2nd day of enteral feeding ( D0 ) were fed BM  ( n = 15 ; 4 dropped out ) or r and omly assigned to A ( n = 11 ; 2 ) or B ( n = 14 ; 1 ) for at least 30 days ( D30 ) . Auditory and visual evoked potentials ( EPs ) and nerve conduction velocity ( NCV ) and plasma and red blood cell ( RBC ) phospholipid composition were determined at D0 and D30 . No difference was found between groups for the D0-D30 changes in EP parameters . The maturation of motor NCV was slower in the B group than in the two other groups . In plasma , the changes were higher in B than in the BM and A groups for linoleic acid ( P < 0.05 ) , in BM versus B group for arachidonic acid ( P < 0.02 ) . In RBC , formula groups displayed higher linoleic acid level than the BM group ( P < 0.05 ) . No difference was found between groups for the changes in arachidonic and docosahexaenoic acids . CONCLUSIONS A balanced supply of n-6 and n-3 PUFA without addition of LC-PUFA allowed an adequate early maturation of the central nerve system . The effects of LC-PUFA on the maturation of NCV remain to be confirmed
There is no evidence that PUFA supplementation in infancy has an effect on infant or childhood allergy , asthma , dermatitis/eczema or food allergy .
However , the quality of evidence was very low .
There was insufficient evidence to determine an effect on allergic rhinitis
BACKGROUND Early dietary intakes may influence the development of allergic disease .
It is important to determine if dietary polyunsaturated fatty acids ( PUFAs ) given as supplements or added to infant formula prevent the development of allergy .
OBJECTIVES To determine the effect of higher PUFA intake during infancy to prevent allergic disease .